Bio-Path Holdings, Inc. (BPTH) Financial Statements (2024 and earlier)

Company Profile

Business Address 4710 BELLAIRE BOULEVARD
BELLAIRE, TX 77401
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,352,0003,444,0006,731,00010,384,00013,650,00017,024,000
Cash and cash equivalents2,352,0003,444,0006,731,00010,384,00013,650,00017,024,000
Prepaid expense632,0001,069,0002,396,0003,587,0002,347,0002,147,000
Other current assets1,818,0001,746,0001,664,0001,644,0002,140,0001,392,000
Total current assets:4,802,0006,259,00010,791,00015,615,00018,137,00020,563,000
Noncurrent Assets
Operating lease, right-of-use asset127,000151,000175,000198,000221,000243,000
Property, plant and equipment92,000114,000136,000158,000181,000203,000
Total noncurrent assets:219,000265,000311,000356,000402,000446,000
TOTAL ASSETS:5,021,0006,524,00011,102,00015,971,00018,539,00021,009,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,241,0001,313,0001,800,0001,576,0002,096,0001,219,000
Accounts payable277,000638,000827,000667,0001,046,000611,000
Accrued liabilities964,000675,000973,000909,0001,050,000608,000
Other undisclosed current liabilities116,000113,000110,000108,000105,000102,000
Total current liabilities:1,357,0001,426,0001,910,0001,684,0002,201,0001,321,000
Noncurrent Liabilities
Long-term debt and lease obligation:     141,000168,000
Liabilities, other than long-term debt25,00055,00085,000113,000  
Operating lease, liability25,00055,00085,000113,000141,000168,000
Other undisclosed noncurrent liabilities1,114,000   (141,000)(168,000)
Total noncurrent liabilities:1,139,00055,00085,000113,000141,000168,000
Total liabilities:2,496,0001,481,0001,995,0001,797,0002,342,0001,489,000
Equity
Equity, attributable to parent2,525,0005,043,0009,107,00014,174,00016,197,00019,520,000
Common stock11,0008,0008,0008,0007,0007,000
Additional paid in capital106,749,000106,071,000105,901,000105,695,000103,753,000103,541,000
Accumulated deficit(104,235,000)(101,036,000)(96,802,000)(91,529,000)(87,563,000)(84,028,000)
Total equity:2,525,0005,043,0009,107,00014,174,00016,197,00019,520,000
TOTAL LIABILITIES AND EQUITY:5,021,0006,524,00011,102,00015,971,00018,539,00021,009,000

Income Statement (P&L) (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Operating expenses(3,276,000)(4,242,000)(5,292,000)(3,986,000)(3,546,000)(3,010,000)
Operating loss:(3,276,000)(4,242,000)(5,292,000)(3,986,000)(3,546,000)(3,010,000)
Nonoperating income (expense)77,0008,00019,00020,00011,0002,000
Investment income, nonoperating5,0008,00019,00020,00011,0002,000
Loss from continuing operations before income taxes:(3,199,000)(4,234,000)(5,273,000)(3,966,000)(3,535,000)(3,008,000)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(3,199,000)(4,234,000)(5,273,000)(3,966,000)(3,535,000)(3,008,000)
Loss before gain (loss) on sale of properties:(3,535,000)(3,008,000)
Other undisclosed net income      
Net loss available to common stockholders, diluted:(3,199,000)(4,234,000)(5,273,000)(3,966,000)(3,535,000)(3,008,000)

Comprehensive Income (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net loss:(3,199,000)(4,234,000)(5,273,000)(3,966,000)(3,535,000)(3,008,000)
Comprehensive loss, net of tax, attributable to parent:(3,199,000)(4,234,000)(5,273,000)(3,966,000)(3,535,000)(3,008,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: